VASCAPA

Why VASCAPA?

Image of a Vascapa Day
Image of a Vascapa Day

The VASCAPA association (Vascular Anomaly Patient Association) has the mission of supporting people affected by vascular anomalies. It was founded in 2012 on the initiative of Professors Laurence Boon and Miikka Vikkula — co‑founders of the Centre for Congenital Vascular Malformations at the Saint‑Luc University Clinics (UCL) in Brussels — as well as patients, former patients, and relatives. As coordinator of the Centre for Vascular Malformations, Professor Boon had observed, in her daily practice, the need for a patient association.

The association focuses on four primary objectives:

  • inform patients and guide them toward the most appropriate care
  • listen to patients and their families, and foster exchange and mutual support among those concerned
  • support research and participate in working groups on rare diseases
  • represent the interests of patients before public authorities, insurers, and healthcare stakeholders, and raise awareness among the general public, policymakers, and healthcare professionals about vascular anomalies and rare diseases

Vascular anomalies affect more than 10% of the population. Their consequences are most often benign, but certain rare and progressive forms can have a major impact on quality of life. Most of these anomalies are rare, require long‑term medical follow‑up, and often call for specialized expertise. This is why VASCAPA is committed to guiding affected individuals so they can receive appropriate care and suitable social support. The association also works with health‑insurance systems to ensure recognition of the specific nature of these conditions and to promote adequate coverage.

To strengthen its impact at the national and European levels, VASCAPA is a member of RaDiOrg (Rare Diseases Organisation Belgium), LUSS (Ligue des Usagers des Services de Santé), VPP (Vlaams Patiëntenplatform), and EURORDIS. It also participates in the VASCERN patient working group, the European network dedicated to rare multisystemic vascular diseases.